Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome

Boehringer Ingelheim

Status: Completed

Conditions: Restless Legs Syndrome

Study type: Observational

Funder types: Industry

Identifiers

NCT01174459

248.678

Details and patient eligibility

About

The survey is conducted to investigate the safety and efficacy of long-term use of BI-Sifrol Tablets in Restless Legs Syndrome (RLS) patients with or without renal dysfunction in routine medical practice.

Enrollment: 571 patients

Sex: All

Ages: 15+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Patient with Restless Legs Syndrome

Exclusion criteria

None

Trial design

571 participants in 1 patient group

Patient with Restless Legs Syndrome